Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Has anyone ever been to Algernons head office?

<< Previous

Bullboard Posts

Next >>

Comment by Mole101on Mar 20, 2021 1:16pm

180 Views

Post# 32845175

RE:Has anyone ever been to Algernons head office?

Is in one of the more expensive areas to rent in Vancouver, right downtown and accessible, very common for companies to share space and resources like secretarial, conference rooms to minimize costs . You actually get way more for your $$ by pooling resources , after all We are a startup on the venture . I rather they spent money in researching than office space

294ever wrote:

Just wondering how big suite #915 could be?

Seems like a bit of a clown car in there.

Businesses currently listed to this address

Westward Advisors Ltd.
First Responder Technologies Inc.
Algernon Pharmaceuticals Inc.
Beyond Medical Technologies inc. (Micron Waste)
Bull Run Capital Inc.
Sadhra and Chow LLP
Hybrid Minerals Inc
Karam Minerals inc

Makes you scratch your head and wonder how connected they are and who's in the middle of it all? Anybody got any idea/input? Just curious is all. With all the missed/slow enrolment dates and delays I wonder if it has anything to do with the CEO likely in all reality not having his own desk. Something weird going on. I don't like it.

External Website. Opens New Window